Everpure, Inc. filings document corporate governance, shareholder voting matters, executive compensation, equity awards, and public-company reporting topics. The company's DEF 14A proxy statement includes disclosures tied to annual meeting matters, compensation tables, equity award values, vesting information, and governance oversight.
Everpure's regulatory record also supports disclosure around its operating company status, single reportable segment, capital and equity-compensation matters, and risk and governance subjects associated with a public technology company.
Everpure, Inc. director Taylor Susan J.S. reported an open-market sale of 8,543 shares of Class A Common Stock on July 9, 2026 at an average price of $81.74 per share. Following this transaction, she directly holds 94,608 Everpure shares.
Everpure, Inc. Chief Product Officer Ajay Singh reported an open-market sale of 9,787 shares of Class A Common Stock on July 8, 2026 at $78.12 per share. Following this transaction, he directly holds 340,939 shares of Everpure Class A Common Stock.
An affiliate of issuer P filed a Form 144 to sell 50,000 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services, with an estimated aggregate value of $4,048,000 and security identifier 332404932, targeting a sale date of July 10, 2026 on the NYSE.
The filing also lists multiple prior Rule 10b5-1 sales over the past three months by various family-related trusts, each disclosing specific share amounts and dollar proceeds.
A shareholder of P has notified of a planned sale of 50,000 common shares through Morgan Stanley Smith Barney LLC Executive Financial Services, with an aggregate market value of $4,048,000.00, to be sold on or after 07/10/2026 on the NYSE. The notice also lists multiple prior Rule 10b5-1 sales by related trusts between April and June 2026, each involving blocks of common stock and significant dollar proceeds.
A shareholder associated with Charles Giancarlo filed to potentially sell 70,000 shares of common stock through Morgan Stanley Smith Barney LLC’s Executive Financial Services program. These shares relate to Restricted Stock Units granted on March 20, 2019. The filing lists an aggregate market value of $5,667,200.00 for the planned sale and references 332,404,932 shares outstanding as of July 10, 2026. Over the prior three months, sales under a Rule 10b5-1 plan included 65,800 shares for $5,267,013.64 on July 9, 2026, 4,200 shares for $336,021.00 on June 30, 2026, and 580,000 shares for $50,845,462.00 on May 11, 2026.
Morgan Stanley Smith Barney LLC submits a Form 144 reporting proposed sale of 65,800 shares. The filing lists prior 10b5-1 sales by Charles Giancarlo of 580,000 shares on 05/11/2026 and 4,200 shares on 06/30/2026, with dollar amounts shown.
The filing names Restricted Stock Units dated 03/20/2019 and is associated with the NYSE; the transaction method is identified as 10b5-1 sales.
Company P submitted a Form 144 notice related to proposed sales of common stock and performance-share awards. The filing lists NYSE as the trading market and a filing date of 07/08/2026. The notice identifies two tranches of performance shares dated 06/20/2026 totaling 9,787 shares in the selling schedule (examples: 2,294 and 7,493).
The excerpt shows fields for securities to be sold and securities sold in the past three months but provides no pricing, purchaser, or proceeds information. The filing appears administrative — a compliance notice of intended resale of shares by an affiliate or reporting person under the securities rules.
Everpure, Inc. CEO and director Giancarlo Charles H reported an open-market sale of 4,200 shares of Class A Common Stock at a weighted average price of $80.01 per share. The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on September 26, 2025.
After the sale, Giancarlo holds 1,815,397 Class A shares directly and 731,414 Class A shares indirectly through the Giancarlo Family Trust UAD 11/02/98. The filing shows no derivative securities remaining.
Charles Giancarlo reported a planned sale of Common stock totaling 4,200 shares by 06/30/2026. The filing shows those shares are associated with an exercise of stock options and a cash transaction through Morgan Stanley Smith Barney LLC. The notice also lists prior 10b5-1 sales on 05/11/2026 of 580,000 shares for $50,845,462.00.